Anpituapar Liquid
NDC Package 44911-0526-1
Package Information
Anpituapar (hypophysis suis, agnus castus, baryta carbonica, calcarea carbonica, iodium, natrum muriaticum, phosphoricum acidum, sepia, thyroidinum (suis), lac caninum, adrenocorticotrophin) liquids May temporarily relieve weakness, weariness, thirst, PMS, and bone pain.****Claims based on traditional homeopathic practice, not accepted medical evidence. This formulation utilizes a liquid delivery system. Marketed by Energique, Inc., this product is identified by NDC 44911-0526.
Identification & Billing
Clinical Specifications
- BARIUM CARBONATE 12 [hp_X]/mL
- CANIS LUPUS FAMILIARIS MILK 16 [hp_X]/mL
- CHASTE TREE FRUIT 12 [hp_X]/mL
- CORTICOTROPIN 15 [hp_C]/mL
- IODINE 12 [hp_X]/mL
- OYSTER SHELL CALCIUM CARBONATE, CRUDE 12 [hp_X]/mL
- PHOSPHORIC ACID 12 [hp_X]/mL
- SEPIA OFFICINALIS JUICE 12 [hp_X]/mL
- SODIUM CHLORIDE 12 [hp_X]/mL
- SUS SCROFA PITUITARY GLAND 8 [hp_X]/mL
- THYROID 12 [hp_X]/mL
Regulatory & Marketing
Hierarchy Structure
- 44911 - Energique, Inc.
- 44911-0526 - Anpituapar
- 44911-0526-1 - 30 mL in 1 BOTTLE, DROPPER
- 44911-0526 - Anpituapar
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 44911-0526-1 identifies a specific commercial package of 30 ml in 1 bottle, dropper of Anpituapar, a human over the counter drug labeled by Energique, Inc.. This liquid is formulated for oral use and contains barium carbonate; canis lupus familiaris milk; chaste tree fruit; corticotropin; iodine; oyster shell calcium carbonate, crude; phosphoric acid; sepia officinalis juice; sodium chloride; sus scrofa pituitary gland; thyroid as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Energique, Inc. on February 25, 2020. The current certification is valid through December 31, 2026.
How is this Energique, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 44911052601. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.